|
| ClinicalTrials.gov identifier | Phase/status/(start dates) | Conditions | Type of cells | Outcome | Country |
|
| NCT02824393 | Early phase 1
Completed
(March 2017) | Urticaria | Autologous MSCs | MSC therapy more effective than conventional treatment, resulted in longer recovery | Turkey |
| NCT01771679 | Phase 1
Phase 2
Suspended
(July 2015) | Photoaging | Allogeneic BMSCs | Ongoing | United States |
| NCT03765957 | Early phase 1
Not yet recruiting
(February 2019) | Psoriasis | MSCs | Ongoing | China |
| NCT02304562 | Phase 1
Unknown
(January 2013) | Sweat gland diseases | UCB-MSCs | Ongoing | China |
| NCT02491658 | Phase 1
Phase 2
Unknown
(April 2015) | Psoriasis vulgaris | UC-MSCs | Ongoing | China |
| NCT02213705 | Phase 1
Phase 2
Unknown
(May 2014) | Systemic scleroderma | Allogeneic MSCs | Ongoing | France |
| NCT03745417 | Phase 1
Phase 2
Recruiting
(August 2018) | Psoriasis | UC-MSCs | Ongoing | China |
| NCT03265613 | Phase 1
Phase 2
Active, not recruiting
(September 2017) | Psoriasis | ADSCs | Ongoing | China |
| NCT03564808 | Phase 2
Recruiting
(June 2018) | Skin pigmentation over contour deformities of the face, trauma, Romberg’s disease | MSCs | Ongoing | Pakistan |
| NCT03392311 | Phase 1
Phase 2
Recruiting
(August 2019) | Psoriasis | ADSCs | Ongoing | China |
| NCT03424629 | Phase 1
Unknown
(June 2018) | Moderate and severe plaque psoriasis | UC-MSCs | Ongoing | China |
| NCT00962923 | Phase 1
Phase 2
Unknown
(August 2009) | Systemic sclerosis | Allogeneic MSCs | Ongoing | China |
| NCT04275024 | Not applicable
Recruiting
(April 2020) | Psoriasis | ADSCs | Ongoing | China |
| NCT02034786 | Phase 1
Unknown
(March 2015) | Aesthetics procedure | Autologous MSCs | Ongoing | Brazil |
| NCT02685722 | Phase 1
Completed
(January 2012) | Skin ulcers | UC-MSCs | — | China |
| NCT04356287 | Phase 1
Phase 2
Not yet recruiting
(October 2020) | Systemic sclerosis | UC-MSCs | Ongoing | — |
| NCT04520022 | Phase 1
Phase 2
Completed
(October 2016) | Recessive dystrophic epidermolysis bullosa | UC-MSCs | — | Korea |
| NCT02975960 | Not applicable
Completed
(October 2016) | Systemic sclerosis | Autologous ADSCs | — | Korea |
| NCT04153630 | Phase 1
Phase 2
Active, not recruiting
(May 2018) | Recessive dystrophic epidermolysis bullosa | BMSCs | Ongoing | Spain |
| NCT03529877 | Phase 1
Phase 2
Recruiting
(January 2019) | Recessive dystrophic epidermolysis bullosa | Allogeneic ABCB5-positive MSCs | Ongoing | United States, Austria, France, German, Italy, United Kingdom |
| NCT02888704 | Phase 1
Completed
(July 2016) | Atopic dermatitis | MSCs | — | Korea |
| NCT03887208 | Phase 1
Phase 2
Completed
(January 2018) | Skin, scar, cutis laxa, keloid, cicatrix | Autologous ADSCs | — | Poland |
| NCT02494752 | Not applicable
Unknown
(August 2015) | Romberg’s disease, craniofacial microsomia, lipodystrophy, mixed connective tissue disease | Fat graft enriched with MSCs | Ongoing | United Kingdom |
| NCT01033552 | Phase 2
Recruiting
(January 2010) | Epidermolysis bullosa | MSCs | Ongoing | United States |
| NCT02582775 | Phase 2
Recruiting
(March 2016) | Epidermolysis bullosa | Allogeneic MSCs | Ongoing | United States |
| NCT02834858 | Phase 1
Unknown
(January 2016) | Peripheral vascular disease, ischemia, diabetic foot | UC-MSCs | Ongoing | China |
| NCT01216865 | Phase 1
Phase 2
Unknown
(January 2011) | Diabetic foot, critical limb ischemia | UC-MSCs | Ongoing | China |
| NCT04464213 | Phase 1
Not yet recruiting
(August 2020) | Diabetic foot ulcer | pMSCs | Ongoing | — |
| NCT04432545 | —
Available
(-) | Diffuse cutaneous systemic sclerosis with refractory pulmonary involvement | Allogeneic MSCs | Ongoing | China |
| NCT01932021 | Not applicable
Unknown
(April 2013) | Skin ulcer | ADSCs | Ongoing | France |
| NCT02304588 | Phase 1
Unknown
(January 2013) | Diabetic foot, lower limb ischemia | MSCs | Ongoing | China |
| NCT03259217 | Phase 1
Unknown
(October 2017) | Diabetic foot ulcers | MSCs seeded in chitosan scaffold | Ongoing | Egypt |
| NCT04104451 | Phase 1
Recruiting
(November 2019) | Diabetic foot ulcer | CLMSCs | Ongoing | United States |
| NCT00955669 | Phase 1
Completed
(August 2009) | Diabetic critical limb ischemia and foot ulcer | Autologous BMSCs | Effective treatment and no recurrence in the next 10-year follow-up span | China |
| NCT04466007 | Phase 2
Not yet recruiting
(October 2020) | Diabetic foot with critical limb ischemia | Allogeneic ADSCs | Ongoing | — |
| NCT03676400 | Not applicable
Completed
(October 2018) | Androgenic alopecia | UC-MSCs | — | Korea |
| NCT02672280 | Phase 1
Phase 2
Unknown
(May 2016) | Wounds, diabetic foot ulcers, burns | Medical collagen membrane with MSCs | Ongoing | China |
| NCT03865394 | Phase 1
Phase 2
Recruiting
(September 2018) | Diabetic foot ulcer | Autologous ADSCs | Ongoing | Poland |
| NCT04497805 | Phase 2
Not yet recruiting
(August 2020) | Diabetic foot ulcer | Allogeneic ADSCs | Ongoing | — |
| NCT03013049 | Not applicable
Unknown
(January 2016) | Vitiligo | DMSCs | Ongoing | India |
| NCT02579369 | Phase 1
Phase 2
Unknown
(October 2015) | Dystrophic epidermolysis bullosa | Allogeneic MSCs | Ongoing | Korea |
| NCT02619877 | Phase 2
Completed
(October 2015) | Diabetic foot ulcer | Allogeneic ADSCs | Complete wound healing in the majority of patients | Korea |
| NCT02796079 | Phase 1
Unknown
(January 2015) | Peripheral vascular disease, ischemia, diabetic foot | MSCs | Ongoing | China |
| NCT03370874 | Phase 3
Unknown
(July 2018) | Diabetic foot ulcer | Allogeneic ADSCs | Ongoing | Korea |
| NCT03183726 | —
Completed
(January 2016) | Diabetic foot ulcer | Allogeneic ADSCs | — | Korea |
| NCT03754465 | Phase 2
Recruiting
(November 2018) | Diabetic foot ulcer | Allogeneic ADSCs | Ongoing | United States |
| NCT03629002 | —
Unknown
(September 2018) | Systemic scleroderma | MSCs | Ongoing | France |
| NCT03060551 | Early phase 1
Completed
(July 2018) | Systemic sclerosis | Autologous ADSCs | Improvement of skin fibrosis, hand edema, active ulcers, and quality of life | Korea |
| NCT03183804 | —
Unknown
(June 12, 2017) | Diabetic foot ulcer | Allogeneic ADSCs | Ongoing | Korea |
| NCT03248466 | Early phase 1
Recruiting
(August 2017) | Diabetic foot ulcer | BMSCs | Ongoing | China |
| NCT03257098 | Phase 1
Phase 2
Recruiting
(November 2017) | Skin ulcer venous stasis chronic | Allogeneic ABCB5-positive MSCs | Ongoing | Germany |
| NCT03252340 | —
Active, not recruiting
(September 2017) | Atopic dermatitis | MSCs | Ongoing | Korea |
| NCT02918123 | Phase 1
Recruiting
(January 2018) | Psoriasis | Allogeneic UCB-MSCs | Ongoing | Korea |
| NCT03183934 | —
Unknown
(July 2017) | Dystrophic epidermolysis bullosa | Allogeneic ADSCs | Ongoing | Korea |
| NCT04173650 | Phase 1
Phase 2
Not yet recruiting
(September 2020) | Dystrophic epidermolysis bullosa | MSC-EVs | Ongoing | — |
| NCT03211793 | Phase 1
Phase 2
Unknown
(November 2018) | Systemic sclerosis
Digital ulcer | MSCs | Ongoing | Netherlands |
| NCT01065337 | Phase 2
Completed
(August 2005) | Diabetic foot | BMSCs | Improvement of microcirculation and complete wound healing in the majority of patients | Germany |
| NCT01686139 | Phase 1
Unknown
(March 2016) | Diabetic foot ulcers | MSCs | Ongoing | Israel |
| NCT04179760 | Phase 1
Phase 2
Recruiting
(March 2020) | Atopic dermatitis | Allogeneic BMSCs | Ongoing | Korea |
| NCT02394886 | Phase 1
Completed
(November 2014) | Diabetic foot ulcer | Allogeneic ADSCs | — | Korea |
| NCT028310752 | Phase 1
Unknown
(January 2015) | Diabetic foot | ADSCs | Ongoing | China |
| NCT04569409 | Phase 3
Recruiting
(July 2020) | Diabetic foot ulcer | Allogeneic ADSCs | Ongoing | Korea |
| NCT03276312 | Not applicable
Completed
(April 2015) | Diabetic foot | Autologous ADSCs | Improvement of healing rate | Italy |
| NCT00815217 | Not applicable
Unknown
(February 2009) | Diabetic wounds | Autologous ADSCs | Ongoing | United States |
| NCT04137562 | Phase 2
Recruiting
(December 2019) | Atopic dermatitis | ADSCs | Ongoing | Korea |
| NCT02742844 | Phase 1
Phase 2
Terminated
(August 2016) | Skin ulcer venous stasis chronic | ABCB5-positive MSCs | Ongoing | Germany |
| NCT02619734 | Phase 1
Unknown
(August 2006) | Chronic leg ulcer
Sickle cell disease | Autologous BMSCs | Ongoing | — |
|
